A global pest leader with a U.S. problem
- North America is the largest region, helped by the Terminix deal, but it is also the weak spot.
- Q1 2025 North America organic growth slowed to 0.7%, with Pest Control at 0.5%.
- International is doing better, with 3.3% organic growth and 4.6% in Pest Control in Q1 2025.
- Management is trying to fix U.S. lead generation with a new digital agency, 36 satellite branches, and a door-to-door pilot.
- The big upside is margin expansion if the Terminix integration works, but the timing is still uncertain.
The U.S. must catch up
Rentokil is a large pest control and hygiene company. The simple bull case is that pests do not go away in a weak economy, service routes can scale, and the company has a strong global base. International is still proving that point, with 3.3% organic growth in Q1 2025 and 4.6% in Pest Control.
The problem is North America. The Terminix deal gave Rentokil more scale in the U.S., but the integration has been harder than planned. North America organic growth slowed to 0.7% in Q1 2025, down from 1.4% in Q3 2024. In Pest Control, North America growth was only 0.5% in Q1 2025.
Management is not waiting. It has changed digital marketing support, opened 36 satellite branches to improve local search leads, and prepared a door-to-door sales pilot. Retention is also a small bright spot, with North America customer retention at 80.4% and colleague retention at 79.8% in Q1 2025.
This is a turnaround story inside a strong global service business. If U.S. leads and contract sales recover, the Terminix scale can matter a lot. If not, the largest region may keep pulling down the group.
Routes, contracts, and local leads
Rentokil makes money by sending trained technicians to homes and businesses to prevent or remove pests. Many jobs repeat, so route density matters. More customers in one local area can mean better use of people, vans, branches, and systems.
The North America business depends heavily on recurring contract work. Management said contract sales make up about 70% of the North America business, and this is where performance is weak. One-time job work is doing respectably, but that is not enough to fix the growth problem.
Terminix is the main moving part. Rentokil is migrating branches onto PestPac, reshaping the branch network, opening satellite branches, and running the RIGHT WAY 2 growth plan. These moves are meant to improve leads, service, and costs.
The model breaks when lead generation falls, technicians leave, customers cancel, or integration work delays savings. That is what investors are watching now.
What Rentokil sells
Residential pest control
Services for homes include regular visits, treatments, and follow-up work. This can be repeat business if customers stay on contracts.
Commercial pest control
Businesses pay Rentokil to keep sites clean, safe, and compliant. The value is in repeat service, local route density, and customer retention.
Termite control
Terminix is a well-known U.S. termite brand. Termite work can be attractive, but it also carries claim risk when damage warranties lead to future costs.
Vector control
This includes work such as mosquito abatement after hurricanes. It can add demand after weather events, but it is less central than core recurring pest contracts.
Hygiene and wellbeing
Rentokil also provides hygiene services, often built around repeat visits and supplies. This adds another route-based service line outside pure pest control.
Chemical product distribution
The company distributes chemical products for pest control and lawn care. This is useful, but the main investment story is still services and North America execution.
North America sets the mood
The mix is rounded from the current Q1 2025 company view: North America is the majority of revenue and International is about 40%. The key caveat is that North America is larger but growing much more slowly.
What can go wrong
U.S. lead generation stays weak
High impact · High oddsNorth America growth was held back by weak inbound leads in Q1 2025. Management changed digital agency support and is using satellite branches to improve local search, but it said organic search was still subdued. If leads do not recover, service capacity and brand scale will not turn into growth.
Contract sales do not recover
High impact · High oddsManagement said job work is performing respectably, but contract performance needs to improve. That matters because recurring contract sales make up about 70% of the North America business. Weak contract adds can hurt growth for more than one quarter.
Terminix integration costs more time
High impact · Medium oddsThe Terminix deal is central to the North America scale story. The 2024 filing noted lower lead and sales growth, over resourcing, overtime, and higher materials and consumables spend. If systems migration or branch changes drag on, expected margin gains may arrive later or be smaller.
Retention remains below the rest of group
Medium impact · Medium oddsNorth America customer retention improved to 80.4% in Q1 2025, and colleague retention improved to 79.8%. That is progress, but the internal view still says both remain below the rest of group. Losing customers or technicians makes route density harder to build.
Termite claims surprise upward
Medium impact · Medium oddsThe 2024 Form 20-F flagged termite damage claim provisions as a critical audit matter. These provisions depend on the volume and value of future claims, customer churn, and discount rates. A bad claims trend could pressure profit and distract management.
In one breath
What does Rentokil Initial do?
Rentokil sells pest control, termite, hygiene, and related services to homes and businesses. Its core work is local and repeat-based, using technicians, routes, branches, and customer contracts.
Why is Terminix important to Rentokil?
Terminix made North America much larger for Rentokil and gave it a major U.S. pest and termite brand. The upside is scale and margin expansion, but the integration has also created execution risk.
What is the main issue with Rentokil stock?
The main issue is whether North America can grow again. Q1 2025 North America organic growth was only 0.7%, while International grew 3.3%, so investors are watching for proof that U.S. leads and contract sales are improving.